The Role of N6-Methyladenosine Modified Circular RNA in Pathophysiological Processes

被引:19
|
作者
Tang, Mei [1 ]
Lv, Yonggang [1 ]
机构
[1] Chongqing Univ, Bioengn Coll, Mechanobiol & Regenerat Med Lab, 174 Shazheng St, Chongqing 400044, Peoples R China
来源
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2021年 / 17卷 / 09期
基金
中国国家自然科学基金;
关键词
Circular RNA; N-6-methyladenosine (m(6)A); Biogenesis; M(6)A-modified circRNA; Pathophysiological processes; PROMOTES CELL-MIGRATION; MESSENGER-RNA; GENE-EXPRESSION; NONCODING RNA; BINDING PROTEIN; NUCLEAR-RNA; TRANSLATION; METHYLATION; IDENTIFICATION; CANCER;
D O I
10.7150/ijbs.60131
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Circular RNA (circRNA) is a type of covalently closed and endogenous non-coding RNA (ncRNA) with tissueand cell-specific expression patterns generated by a non-canonical splicing event. Previous reports have indicated that circRNAs exert their functions in different ways, thereby participating in various pathophysiological processes. N6-methyladenosine (m6A) methylation occurs in the N6-position, which is the most abundant and conserved internal transcriptional modification in eukaryotes, including mRNA and ncRNAs. Accumulating evidences confirm that m6A modification also exists in the circRNA and greatly affects the biological functions of circRNA. Their dysregulated expression can be a cause of various pathophysiological processes, such as spermatogenesis, myoblast differentiation, cancer, cardiovascular disease, mental illness and so on. Understanding the role of m6A-modified circRNAs in pathophysiological processes may contribute to better understanding the physiological mechanisms and develop new biomarkers. This review summarizes the regulatory mechanism of m6A modification on circRNA metabolism and the role of m6A-modified circRNAs in pathophysiological processes. This article may pave the way for a better understanding of the role of epigenetically modified circRNAs in pathophysiological process.
引用
收藏
页码:2262 / 2277
页数:16
相关论文
共 50 条
  • [21] Role of N6-Methyladenosine RNA Modification in Cardiovascular Disease
    Song, Dandan
    Hou, Jianhua
    Wu, Junduo
    Wang, Junnan
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [22] The Role of N6-Methyladenosine in Inflammatory Diseases
    Xu, Haojun
    Lin, Changjie
    Yang, Jinghan
    Chen, Xi
    Chen, Yingyu
    Chen, Jianguo
    Guo, Aizhen
    Hu, Changmin
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [23] The potential roles of RNA N6-methyladenosine in atherosclerosis
    Chen, L-H
    Zhao, Y-Y
    Huang, L.
    Li, Y-Z
    Xu, H-Q
    Yang, C.
    Zhang, C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (04) : 1075 - 1083
  • [24] RNA N6-Methyladenosine Modifications and the Immune Response
    Wang, Ya-Nan
    Yu, Chen-Yang
    Jin, Hong-Zhong
    JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [25] N6-Methyladenosine Modification Controls Circular RNA Immunity
    Chen, Y. Grace
    Chen, Robert
    Ahmad, Sadeem
    Verma, Rohit
    Kasturi, Sudhir Pai
    Amaya, Laura
    Broughton, James P.
    Kim, Jeewon
    Cadena, Cristhian
    Pulendran, Bali
    Hur, Sun
    Chang, Howard Y.
    MOLECULAR CELL, 2019, 76 (01) : 96 - +
  • [26] N6-methyladenosine (m6A) RNA modification in tumor immunity
    Zheng, Siyi
    Han, Hui
    Lin, Shuibin
    CANCER BIOLOGY & MEDICINE, 2022, 19 (04) : 385 - 397
  • [27] Inducible and reversible RNA N6-methyladenosine editing
    Shi, Huaxia
    Xu, Ying
    Tian, Na
    Yang, Ming
    Liang, Fu-Sen
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [28] New horizons for the role of RNA N6-methyladenosine modification in hepatocellular carcinoma
    Li, Yu-jia
    Qiu, Yang-ling
    Li, Meng-ran
    Shen, Min
    Zhang, Feng
    Shao, Jiang-juan
    Xu, Xue-fen
    Zhang, Zi-li
    Zheng, Shi-zhong
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (06) : 1130 - 1141
  • [29] N6-Methyladenosine RNA Modification: A Potential Regulator of Stem Cell Proliferation and Differentiation
    Wei, Bo
    Zeng, Meiyu
    Yang, Jing
    Li, Shuainan
    Zhang, Jiantao
    Ding, Nan
    Jiang, Zhisheng
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [30] N6-Methyladenosine RNA Methylation in Cardiovascular Diseases
    Liu, Chi
    Gu, Lei
    Deng, Wenjuan
    Meng, Qianchao
    Li, Nan
    Dai, Guifeng
    Yu, Suli
    Fang, Hong
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9